Breast cancer
Results
Phase 3
This trial was for people whose breast cancer had tested positive for the HER2 protein. This isHER2 positive breast cancer.
Cancer Research UK supported this trial.
This trial was open for people to join between 2010 and 2015. The team published the results in 2021.
Recruitment start: 15 November 2010
Recruitment end: 30 September 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Prof Nigel Bundred
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
GlaxoSmithKline (GSK)
Institute of Cancer Research (ICR)
ICR Clinical Trials and Statistics Unit
NIHR Clinical Research Network: Cancer
University Hospital of South Manchester (UHSM)
This is Cancer Research UK trial number CRUK/08/002.
Last reviewed: 12 Jul 2023
CRUK internal database number: 1701
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
